Mariners shuffle roster after Matt Brash goes on 15-day IL; Miles Mastrobuoni returns to active roster

The Seattle Mariners moved quickly Wednesday afternoon, turning a brief window of roster stability into a full reset for both their bullpen and their late-inning options. Seattle placed right-hander Matt Brash on the 15-day injured list with a right lat strain, retroactive to June 9, and the transaction is likely to affect how the team manages high-leverage innings in the near term.

The Mariners also activated utilityman Miles Mastrobuoni, who returned to action after being on the 60-day injured list. Mastrobuoni, a versatile bat and baserunner, had been sidelined since spring training with an oblique injury that limited his time in Arizona. According to the report, the injury also cost him most of his opportunities during the World Baseball Classic cycle with Team Italy.

The third piece of the flurry was the corresponding roster work to make room for Mastrobuoni’s activation and to adjust the active pitching staff. In the wake of the Brash IL move and the Mastrobuoni activation, Seattle optioned infielder Ryan Bliss to Triple-A Tacoma, a move that preserves regular-season flexibility while shifting playing time to the minors.

To fill the immediate gap on the roster, the Mariners recalled right-hander Domingo González and activated Mastrobuoni. The sequence culminated in a 40-man roster squeeze that led the team to designate right-hander Yosver Zulueta for assignment, clearing a spot for the active move. The DFA suggests Seattle is comfortable evaluating which player fits best in the bullpen and in-game leverage plans over the next few weeks.

The Brash injury is the most consequential development because it touches the heart of a bullpen plan that typically relies on repeatable, high-velocity, high-intent pitching. The report characterizes Brash’s current ailment as a lat strain in the same muscle area that previously sidelined him in May, when the setback was described as inflammation. A strain, the report notes, tends to carry a longer recovery window than inflammation, which increases the chance that Seattle could be without a key option for more than a couple of short stints.

For Mastrobuoni, the immediate role is likely to be both situational and flexible. The report describes him as replacing Bliss on the roster, with additional utility value that can extend beyond pinch-hitting into pinch-running and other matchup-dependent scenarios. That matters for a team trying to keep late-game choices coherent when bullpen usage patterns are forced to adjust around injured availability.

What to watch next is whether Seattle’s rotation of bullpen arms remains stable as Brash stays out and how long González and other recalled options are asked to cover for innings they would not normally pitch. The other key question is how quickly Mastrobuoni ramps back to game speed after a long stretch away, particularly if Seattle needs him to be ready for end-game baserunning assignments and late-inning roster construction. Without further official updates, the full timeline for Brash’s return remains uncertain beyond the 15-day window itself.